Pharmacological interventions for preventing bone density loss in critically ill people
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the benefits (reduced incidence of vertebral, non‐vertebral and hip fracture, improved quality of life) and harms (i.e. adverse effects) of pharmacological interventions for the prevention of bone density loss in critically ill patients.